Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy PDS Biotechnology stock

Learn how to easily invest in PDS Biotechnology stock.

PDS Biotechnology Corp is a biotechnology business based in the US. PDS Biotechnology shares (PDSB) are listed on the NASDAQ and all prices are listed in US Dollars. PDS Biotechnology employs 22 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in PDS Biotechnology

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – PDSB – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

PDS Biotechnology stock price (NASDAQ: PDSB)

Use our graph to track the performance of PDSB stocks over time.

PDS Biotechnology shares at a glance

Information last updated 2022-09-27.
Latest market close$3.19
52-week range$2.91 - $15.82
50-day moving average $4.36
200-day moving average $5.39
Wall St. target price$19.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.84

Buy PDS Biotechnology shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy PDS Biotechnology stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

PDS Biotechnology price performance over time

Historical closes compared with the close of $3.19 from 2022-09-28

1 week (2022-09-21) -3.33%
1 month (2022-08-29) -26.83%
3 months (2022-06-29) -15.61%
6 months (2022-03-29) -49.76%
1 year (2021-09-29) -78.52%
2 years (2020-09-29) 36.91%
3 years (2019-09-27) 3.4843
5 years (2017-09-28) 10.72

PDS Biotechnology financials

Gross profit TTM $0
Return on assets TTM -27.04%
Return on equity TTM -44.32%
Profit margin 0%
Book value $1.81
Market capitalisation $85.1 million

TTM: trailing 12 months

PDS Biotechnology share dividends

We're not expecting PDS Biotechnology to pay a dividend over the next 12 months.

Have PDS Biotechnology's shares ever split?

PDS Biotechnology's shares were split on a 1:20 basis on 17 March 2019. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your PDS Biotechnology shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for PDS Biotechnology shares which in turn could have impacted PDS Biotechnology's share price.

PDS Biotechnology share price volatility

Over the last 12 months, PDS Biotechnology's shares have ranged in value from as little as $2.91 up to $15.82. A popular way to gauge a stock's volatility is its "beta".

PDSB.US volatility(beta: 1.77)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while PDS Biotechnology's is 1.7667. This would suggest that PDS Biotechnology's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

PDS Biotechnology overview

PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies, and cervical cancer. The company is also developing various product candidates, which are in preclinical trials, including PDS0102 T-cell receptor gamma alternate reading frame protein (TARP) for treating prostate and breast cancers; PDS0103 (MUC-1) for ovarian, colorectal, lung, and breast cancers; and PDS0104, which include Tyrosinase-related protein 2 for the treatment of melanoma. In addition, it is developing PDS0201 for treating tuberculosis; PDS0202, an influenza vaccine candidate; and PDS0203, a vaccine for the prevention of COVID-19. The company has a license and collaboration agreements with National Institutes of Health, Merck Eprova AG, The U. S. Department of Health and Human Services, and MSD International GmbH.

Frequently asked questions

What percentage of PDS Biotechnology is owned by insiders or institutions?
Currently 14.259% of PDS Biotechnology shares are held by insiders and 19.542% by institutions.
How many people work for PDS Biotechnology?
Latest data suggests 22 work at PDS Biotechnology.
When does the fiscal year end for PDS Biotechnology?
PDS Biotechnology's fiscal year ends in December.
Where is PDS Biotechnology based?
PDS Biotechnology's address is: 25B Vreeland Road, Florham Park, NJ, United States, 07932
What is PDS Biotechnology's ISIN number?
PDS Biotechnology's international securities identification number is: US70465T1079
What is PDS Biotechnology's CUSIP number?
PDS Biotechnology's Committee on Uniform Securities Identification Procedures number is: 279870109

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site